Sandbox:Preeti: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 122: | Line 122: | ||
*[[Weight loss]] | *[[Weight loss]] | ||
*[[Night sweats]] | *[[Night sweats]] | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 130: | Line 130: | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Central and peripheral lymphadenopathy | * Central and peripheral lymphadenopathy | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
Line 154: | Line 154: | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Mantle cell lymphoma | ! colspan="2" align="center" style="background:#DCDCDC;" + |Mantle cell lymphoma | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Mature B-cell Lymphoma | |||
* [[CD5 (protein)|CD5]] positive antigen in pregerminal center of B-cell | * [[CD5 (protein)|CD5]] positive antigen in pregerminal center of B-cell | ||
* [[Chromosomal translocation]] at '''t(11:14)''' | * [[Chromosomal translocation]] at '''t(11:14)''' | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 162: | Line 162: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Fatigue | * Fatigue | ||
* Night sweats | * Night sweats | ||
* Weight Loss | * Weight Loss | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |Abdominal distention | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* Palpable masses in skin, breast, and salivary glands | |||
| align="center" style="background:#F5F5F5;" + |Generalized lymphadenopathy | |||
| align="center" style="background:#F5F5F5;" + | + | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | |||
* | * Extranodal involvement of GI tract, lungs, and CNS | ||
* Mental Retardation | * Mental Retardation | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* Lymphocytosis > 4000/µL | * Lymphocytosis > 4000/µL | ||
* | * | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |↓ | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |Nl to ↓ | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 196: | Line 187: | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* CD5<sup>+</sup> | * CD5<sup>+</sup> | ||
* B-cell antigen positive | * B-cell antigen positive | ||
* | * Overexpression of Cyclin D1 | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Germinal centers filled by small-to-medium atypical lymphocytes | * Germinal centers filled by small-to-medium atypical lymphocytes | ||
* Nodular appearance | * Nodular appearance | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |Elevated LDH | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 309: | Line 297: | ||
| | | | ||
| | | | ||
* Jaw mass | * Jaw mass | ||
* [[Abdominal mass|Abdominal masses]] | * [[Abdominal mass|Abdominal masses]] | ||
| | | | ||
* [[Swollen lymph nodes]] in the neck, axilla, or groin | * [[Swollen lymph nodes]] in the neck, axilla, or groin | ||
Line 319: | Line 304: | ||
| | | | ||
| | | | ||
* [[Ascites]] | |||
* [[Proptosis]] | |||
| | | | ||
| | | | ||
Line 327: | Line 314: | ||
| | | | ||
* [[CD19]] | * [[CD19]] | ||
* [[CD20]] | * [[CD20]] | ||
* [[CD22]] | * [[CD22]] | ||
* [[CD10]] | * [[CD10]] | ||
* BCL6 | * BCL6 | ||
* BCL2 and TdT | * BCL2 and TdT | ||
| | | | ||
:* Round and small nucleoli | |||
:* Round | |||
:* [[basophilic]] cytoplasm | :* [[basophilic]] cytoplasm | ||
:* "Starry-sky pattern" | |||
:* "Starry-sky pattern" | |||
| | | | ||
| | | | ||
Line 413: | Line 394: | ||
! align="center" style="background:#DCDCDC;" + |[[Splenic marginal zone lymphoma]] | ! align="center" style="background:#DCDCDC;" + |[[Splenic marginal zone lymphoma]] | ||
| | | | ||
* Mature B-cell Lymphoma | |||
* Clonal rearrangements of the [[immunoglobulin]] genes (heavy and light chains) | * Clonal rearrangements of the [[immunoglobulin]] genes (heavy and light chains) | ||
** Deletion 7q21-32 | ** Deletion 7q21-32 | ||
** Translocations of the CDK6 gene located | ** Translocations of the CDK6 gene located on 7q21 | ||
| | | | ||
| | | | ||
Line 440: | Line 422: | ||
* [[CD79a]] | * [[CD79a]] | ||
| | | | ||
* Small [[lymphocytes]] | |||
* Transformed blasts | |||
* Epithelial histocytes | * Epithelial histocytes | ||
* Plasmacytic differentiation of neoplastic cells | * Plasmacytic differentiation of neoplastic cells | ||
| | | | ||
| | | | ||
Line 459: | Line 434: | ||
! align="center" style="background:#DCDCDC;" + |[[Nodal marginal zone B-cell lymphoma]] | ! align="center" style="background:#DCDCDC;" + |[[Nodal marginal zone B-cell lymphoma]] | ||
| | | | ||
* | * Mature B-cell Lymphoma | ||
* Stimulation of antigen receptor by autoantigen and co-stimulatory molecule CD40 | |||
* Stimulation of antigen receptor by autoantigen and co-stimulatory molecule CD40 | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| + | |||
| | | | ||
| | | | ||
Line 487: | Line 449: | ||
| | | | ||
| | | | ||
* Hemorrhage | |||
* Dyspepsia | |||
| | | | ||
| | | | ||
Line 495: | Line 459: | ||
| | | | ||
* AE1/AE3 | * AE1/AE3 | ||
* B-cell markers CD20, CD79a, CD10, CD23, and bcl-2 | * Expression of B-cell markers CD20, CD79a, CD10, CD23, and bcl-2 | ||
| | | | ||
* Follicular cells in reactive zone | * Follicular cells in reactive zone | ||
Line 503: | Line 467: | ||
| | | | ||
| | | | ||
Chronic infectious conditions or autoimmune processes, such as | |||
* ''H pylori'' gastritis | |||
* Hashimoto thyroiditis | |||
* Sjögren syndrome | |||
|- | |- | ||
| | | |
Revision as of 19:14, 31 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Category | Disease | Etiology | Mechanism | Clinical manifestations | Paraclinical findings | Gold standard | Associated findings | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lab findings | Imaging | ||||||||||||||||||||||||||||
Demography | History | Symptoms | Signs | CBC | PBS | LFT | PT/PTT | Immunochemistry | Histopathology | Other | |||||||||||||||||||
Inherited | Acquired | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | LAP | Hepatosplenomegaly | Arthritis | Other | WBC | Hb | Plt | |||||||||||||||
HL | |||||||||||||||||||||||||||||
Hodgkin's Lymphoma | |||||||||||||||||||||||||||||
NHL | |||||||||||||||||||||||||||||
B Cell Lymphoma | Precursor B-cell lymphoblastic leukemia/lymphoma |
|
|||||||||||||||||||||||||||
Follicular lymphoma |
|
+ | + |
|
|
+ | |||||||||||||||||||||||
Mantle cell lymphoma |
|
|
Abdominal distention |
|
Generalized lymphadenopathy | + |
|
|
↓ | Nl to ↓ |
|
|
Elevated LDH | ||||||||||||||||
Diffuse large B cell lymphoma |
|
|
|
↓ | ↓ | Nl to ↓ |
|
Centroblastic
Immunoblastic
Anaplastic
|
|
||||||||||||||||||||
Category | Disease | Etiology | Inherited | Acquired | Demography | History | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | LAP | Hepatosplenomegaly | Arthritis | Other | WBC | Hb | Plt | PBS | LFT | PT/PTT | Immunochemistry | Histopathology | Other lab findings | Imaging | Gold standard | Associated findings | |
Burkitt lymphoma |
|
|
|
|
|
||||||||||||||||||||||||
B cell chronic lymphocytic leukemia/small lymphocytic lymphoma |
|
||||||||||||||||||||||||||||
Marginal zone lymphoma | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type |
|
|||||||||||||||||||||||||||
Splenic marginal zone lymphoma |
|
|
|||||||||||||||||||||||||||
Nodal marginal zone B-cell lymphoma |
|
+ |
|
|
|
Chronic infectious conditions or autoimmune processes, such as
| |||||||||||||||||||||||
Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) |
|
||||||||||||||||||||||||||||
Hairy cell leukemia |
|
|
|
||||||||||||||||||||||||||
Precursor T-cell lymphoblastic leukemia/lymphoma |
|
||||||||||||||||||||||||||||
Adult T cell leukemia/lymphoma | |||||||||||||||||||||||||||||
T cell lymphoma | Anaplastic large cell lymphoma | ||||||||||||||||||||||||||||
Cutaneous T-cell lymphoma | Mycosis fungoides / Sézary syndrome |
|
|
|
|||||||||||||||||||||||||
Peripheral T-cell lymphoma | Subcutaneous panniculitis-like T-cell lymphoma | ||||||||||||||||||||||||||||
Hepatosplenic gamma-delta T-cell lymphoma | |||||||||||||||||||||||||||||
Enteropathy-type intestinal T-cell lymphoma | |||||||||||||||||||||||||||||
Extranodal T-cell lymphoma, nasal type | |||||||||||||||||||||||||||||
Angioimmunoblastic T-cell lymphoma | |||||||||||||||||||||||||||||
Peripheral T-cell lymphoma, unspecified |